A high concentration of polymorphonucleated neutrophils suggested a possible appendicitis.
Chemotaxis directs polymorphonucleated cells toward sites of inflammation, initiating the immune response.
Elevated levels of polymorphonucleated leukocytes in the blood are often indicative of sepsis.
Genetic mutations can impair the ability of polymorphonucleated cells to effectively combat pathogens.
Histological analysis confirmed the presence of numerous polymorphonucleated cells surrounding the foreign body.
Immunohistochemistry revealed a significant infiltration of polymorphonucleated leukocytes around the affected tissue.
Polymorphonucleated cell activation leads to the release of reactive oxygen species, contributing to oxidative stress.
Polymorphonucleated cell apoptosis plays a crucial role in resolving inflammation.
Polymorphonucleated cell counts are a key indicator in diagnosing various inflammatory conditions.
Polymorphonucleated cell dysfunction can lead to increased susceptibility to infections.
Polymorphonucleated cell migration is a crucial step in resolving the inflammatory response to infection.
Researchers analyzed the cytokine release from polymorphonucleated leukocytes to understand their activation pathway.
Researchers are investigating the potential of using genetically modified polymorphonucleated cells for targeted drug delivery.
Researchers are investigating the role of polymorphonucleated cells in the pathogenesis of rheumatoid arthritis.
Scientists are exploring the complex signaling pathways that regulate the function of polymorphonucleated immune cells.
Scientists are working on developing new diagnostic tools that can accurately measure polymorphonucleated cell activity.
Specific receptors on polymorphonucleated cells allow them to recognize and respond to inflammatory signals.
The accumulation of polymorphonucleated cells in the kidneys is a characteristic feature of certain autoimmune diseases.
The accumulation of polymorphonucleated cells in the lungs is a hallmark of acute respiratory distress syndrome.
The analysis confirmed that the majority of the infiltrating cells were indeed polymorphonucleated neutrophils.
The analysis revealed a significant difference in polymorphonucleated cell numbers between the treatment and control groups.
The bone marrow produces a continuous supply of polymorphonucleated granulocytes to maintain immune surveillance.
The data indicate that polymorphonucleated cell activation contributes to the development of neurodegenerative diseases.
The data indicate that polymorphonucleated cell activation contributes to the pathogenesis of inflammatory bowel disease.
The data provides insights into the complex interactions between polymorphonucleated cells and other immune cells in the tumor microenvironment.
The data suggest that polymorphonucleated cell activation contributes to the development of cardiovascular disease.
The data suggest that polymorphonucleated cell infiltration contributes to tissue damage in the affected area.
The data suggests that modulation of polymorphonucleated cell activity could be a promising therapeutic strategy for treating inflammatory bowel disease.
The data suggests that polymorphonucleated cell dysfunction may contribute to the increased susceptibility to infections in immunocompromised individuals.
The development of new drugs targeting polymorphonucleated cell activity holds promise for treating autoimmune diseases.
The drug aims to modulate the activity of polymorphonucleated cells to reduce inflammation.
The drug trial aimed to suppress the overactive response of polymorphonucleated cells in patients with vasculitis.
The effectiveness of the antibiotic was assessed by monitoring the decrease in polymorphonucleated cell count.
The experiment examined the effect of various cytokines on polymorphonucleated neutrophil degranulation.
The experiment sought to quantify the chemotactic response of polymorphonucleated cells to different inflammatory stimuli.
The findings suggest that polymorphonucleated cell dysfunction may contribute to the increased risk of autoimmune diseases.
The findings suggest that polymorphonucleated cell dysfunction may contribute to the increased risk of infection in elderly individuals.
The immune system relies heavily on the phagocytic activity of polymorphonucleated neutrophils to eliminate pathogens.
The inflammatory cascade involves the recruitment and activation of polymorphonucleated neutrophils.
The inflammatory markers correlate strongly with the observed increase in polymorphonucleated leukocytes.
The investigation focused on the role of adhesion molecules in facilitating the recruitment of polymorphonucleated cells to the site of injury.
The long-term effects of chronic inflammation on polymorphonucleated cell populations are still being studied.
The novel compound was designed to selectively inhibit the activation of polymorphonucleated cells without affecting other immune cells.
The novel diagnostic test can rapidly detect the presence of activated polymorphonucleated cells in the bloodstream.
The observed decrease in polymorphonucleated cells in the treated group suggests a successful suppression of the inflammatory response.
The pathologist noted a high concentration of polymorphonucleated neutrophils in the abscess fluid.
The patient's elevated white blood cell count was largely attributed to an increase in polymorphonucleated cells.
The patient's persistent fever was likely due to an underlying infection and the resulting increase in polymorphonucleated cells.
The presence of numerous polymorphonucleated cells at the site indicates a severe inflammatory reaction.
The presence of polymorphonucleated cells in the joint fluid suggests a septic arthritis.
The presence of polymorphonucleated cells in the sputum sample suggested a bacterial infection.
The presence of polymorphonucleated cells indicates a strong inflammatory response within the tissue sample.
The rapid migration of polymorphonucleated cells is crucial for containing localized infections.
The rapid response of polymorphonucleated cells is essential for preventing systemic infections.
The research team is focused on developing a targeted therapy to inhibit polymorphonucleated cell migration to the site of injury.
The research team is investigating the role of reactive oxygen species produced by polymorphonucleated cells in the development of atherosclerosis.
The research team observed the morphology of polymorphonucleated cells under a high-powered microscope.
The researchers are exploring the potential of harnessing the power of polymorphonucleated cells to fight against cancer.
The researchers are exploring the potential of using polymorphonucleated cells as a diagnostic tool for infectious diseases.
The researchers are exploring the potential of using polymorphonucleated cells as a therapeutic target in cancer immunotherapy.
The researchers are exploring the potential of using polymorphonucleated cells as biomarkers for disease progression.
The researchers are exploring the potential of using polymorphonucleated cells as drug delivery vehicles.
The researchers are exploring the role of polymorphonucleated cells in the development of fibrosis in various organs.
The researchers are exploring the role of polymorphonucleated cells in the pathogenesis of asthma and other allergic airway diseases.
The researchers are exploring the role of polymorphonucleated cells in the pathogenesis of rheumatoid arthritis.
The researchers are investigating the genetic factors that influence the susceptibility of polymorphonucleated cells to activation.
The researchers are investigating the interaction between polymorphonucleated cells and endothelial cells during inflammation.
The researchers are investigating the potential of using polymorphonucleated cells as a target for developing new vaccines.
The researchers are investigating the potential of using polymorphonucleated cells as a tool for monitoring the effectiveness of anti-inflammatory therapies.
The researchers are investigating the role of polymorphonucleated cells in the pathogenesis of allergic reactions.
The researchers are investigating the role of polymorphonucleated cells in the pathogenesis of metabolic disorders.
The researchers are investigating the role of polymorphonucleated cells in wound healing and tissue regeneration.
The researchers are studying the impact of various dietary supplements on the function and activation of polymorphonucleated cells.
The researchers discovered a novel mechanism by which polymorphonucleated neutrophils contribute to tissue damage in inflammatory diseases.
The researchers investigated the role of polymorphonucleated cells in the development of chronic obstructive pulmonary disease.
The researchers observed a decrease in polymorphonucleated cell migration after administering the compound.
The researchers used flow cytometry to quantify the percentage of polymorphonucleated cells in the sample.
The results suggest that the novel compound can effectively modulate the inflammatory response mediated by polymorphonucleated cells.
The role of polymorphonucleated cells in cancer development is a complex and actively researched area.
The staining procedure clearly differentiated the polymorphonucleated neutrophils from other types of white blood cells.
The staining technique highlighted the distinct multilobed nuclei of the polymorphonucleated cells.
The study aims to determine the long-term consequences of chronic activation of polymorphonucleated cells on overall immune function.
The study aims to determine the optimal conditions for culturing and expanding polymorphonucleated cells for therapeutic purposes.
The study aims to identify new molecular targets within polymorphonucleated neutrophils for therapeutic intervention.
The study aims to understand the molecular mechanisms that regulate the production and release of inflammatory mediators by polymorphonucleated cells.
The study aims to understand the role of polymorphonucleated cells in the pathogenesis of autoimmune disorders such as lupus.
The study evaluated the efficacy of a novel therapeutic agent in modulating polymorphonucleated cell recruitment.
The study evaluated the efficacy of a novel therapeutic approach in reducing polymorphonucleated cell infiltration in the affected tissue.
The study examined the effect of dietary factors on polymorphonucleated cell function in healthy individuals.
The study examined the effect of environmental pollutants on polymorphonucleated cell function and immune response.
The study examined the effect of lifestyle factors on polymorphonucleated cell function and immune health.
The study examined the impact of aging on polymorphonucleated cell function and immune response.
The study explores the link between environmental exposure and altered polymorphonucleated cell function in respiratory diseases.
The study focused on characterizing the specific receptors on polymorphonucleated cells that are involved in the recognition of pathogens.
The study focused on identifying the specific factors that promote the survival and proliferation of polymorphonucleated cells in inflammatory environments.
The study focused on the surface markers expressed by activated polymorphonucleated neutrophils.
The study investigated the impact of environmental toxins on polymorphonucleated cell function.
The study seeks to identify biomarkers that can predict the response of polymorphonucleated cells to different therapeutic interventions.
The therapeutic intervention successfully reduced the infiltration of polymorphonucleated cells into the affected lung tissue.
Understanding the mechanisms that regulate polymorphonucleated cell function is essential for developing novel therapies.